RP
AMGN icon

Raiff Partners’s Amgen AMGN Stock Holding History

Raiff Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-12,000
Closed -$1.84M – 25
2015
Q2 		$1.84M Buy
+12,000
New +$1.92M 2.01% 16
2013
Q3 		– Sell
-40,000
Closed -$3.95M – 31
2013
Q2 		$3.95M Buy
+40,000
New +$4.15M 2.93% 16

Other funds holding AMGN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Raiff Partners's AMGN Position: Q3 2015 in Review

Raiff Partners sold out of Amgen (AMGN) in Q3 2015, closing a stake of 12,000 shares — an estimated $1.84M sold.

Raiff Partners first reported a position in AMGN in Q2 2013 and held it in 2 quarters. The position peaked at $3.95M in Q2 2013. 1,380 funds tracked by Wall St. Rank hold AMGN as of Q3 2015.

  • Raiff Partners reported no remaining Amgen position as of Q3 2015 after selling out during the quarter.
  • Raiff Partners sold 12,000 Amgen shares in Q3 2015, an estimated $1.84M.
  • Raiff Partners first reported a position in Amgen in Q2 2013 and held it in 2 quarters.
  • Raiff Partners's Amgen position peaked at $3.95M in Q2 2013.
  • 1,380 funds tracked by Wall St. Rank held Amgen as of Q3 2015.

Based on Raiff Partners's 13F filing for Q3 2015, filed 13 Nov 2015.